对胸部瘤宏分子疗法的免疫学和营养观点
Hao Rong1, Min Zheng2, YunXiang Qi3
1Department of Thoracic Surgery, Sichuan Clinical Research Center for Cancer, Sichuan Cancer Hospital and Institute, Sichuan Cancer Center, University of Electronic Science and Technology of China, Chengdu, China.
Frontiers in immunology
|October 1, 2025
概括
新型宏分子药物显示出治疗肺癌等胸部瘤的前景,提供新的组合疗法. 尽管面临挑战,但这些先进的治疗方法有可能改善患者的治疗结果,并减少癌症负担.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 生物技术是生物技术.
背景情况:
- 胸部瘤的发病率和死亡率很高,传统疗法的疗效有限.
- 宏分子药物,包括单克隆抗体和抗体-药物联合体 (ADC),为胸部癌症提供了新的治疗途径.
- 目前的组合疗法 (免疫疗法,化疗,向疗法) 可以改善存活率,但存在安全问题.
研究的目的:
- 审查新型宏分子药物在治疗胸部瘤中的应用.
- 为未来的研究和这些先进疗法的临床转化提供见解.
- 突出宏分子药物的潜力,以应对胸部癌症治疗中的挑战.
主要方法:
- 文献综述侧重于对胸部恶性瘤的宏分子药物开发的最新进展.
- 对结合免疫治疗,化疗和向治疗的治疗策略的分析.
- 检查新型宏分子药物的临床应用中的挑战和机遇.
主要成果:
- 大分子药物在治疗肺癌,乳腺癌和食道癌症方面表现有前途.
- 组合疗法改善了患者生存指标,但与免疫相关的不良事件和毒性有关.
- 发育方面的挑战包括抗体亲和力,链接器设计和传递系统.
结论:
- 大分子药物为技术创新,组合疗法和胸部瘤个性化治疗提供了巨大的潜力.
- 克服瘤异质性,耐药性和成本等挑战对于更广泛的临床应用至关重要.
- 预计这些药物将改善患者的生活质量,并减少癌症的社会经济负担.
更多相关视频
09:15Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine
Published on: February 24, 2023
3.9K
07:55Flow Cytometry-Based Isolation and Therapeutic Evaluation of Tumor-Infiltrating Lymphocytes in a Mouse Model of Pancreatic Cancer
Published on: January 17, 2025
1.7K
相关概念视频
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
Cytotoxic T Cells-mediated Immune Response
6.5K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
6.5K
The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
